Evidence map›Paper›PMID 42106885›Full record

ReviewActa neuropathologica communications2026

Decoding brain arteriovenous malformations: from genetic insights to modeling the vascular maze.

Kang Xie, Ying Wang, Shifu Li, Hua Chen, Longbo Zhang

Abstract readReview
In one paragraph

Review in Acta neuropathologica communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kang XieDepartments of Neurosurgery, and National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China.
Ying WangDepartments of Neurosurgery, and National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China.
Shifu LiDepartments of Neurosurgery, and National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China.
Hua ChenDepartment of Neurosurgery, Changde Hospital, Xiangya School of Medicine, Central South University (The First People's Hospital of Changde City), Changde, China. 936483206@qq.com.
Longbo ZhangDepartments of Neurosurgery, and National Clinical Research Center for Geriatric Diseases, Xiangya Hospital, Central South University, Changsha, 410008, China. zhanglb@csu.edu.cn.

Funding

Science Fund for Distinguished Young Scholars of Hunan Province 2024JJ2091
6 · The paper itself

Abstract

Brain arteriovenous malformations (bAVMs) are complex cerebrovascular anomalies characterized by a tangle of dysplastic vessels, including feeding arteries, a nidus, and draining veins, with the absence of an intervening capillary bed. bAVMs pose a significant risk of severe complications, such as intracranial hemorrhage, seizures, and progressive neurological deficits, leading to substantial morbidity and mortality. While advancements in treatments, including microsurgical resection, endovascular embolization, and stereotactic radiosurgery, have improved patient outcomes, the underlying pathogenesis of bAVMs remains poorly understood. The emergence of next-generation sequencing (NGS) has identified critical genetic mutations implicated in bAVMs, such as KRAS and BRAF, which dysregulate the MAPK signaling pathway. Additionally, hereditary forms of bAVMs, including those associated with hereditary hemorrhagic telangiectasia (HHT), are linked to mutations in TGF-β signaling pathway genes, such as ENG and ALK1. These discoveries have spurred the development of genetically engineered animal models (GEAMs) that faithfully recapitulate key pathological features of bAVMs, including vascular dysplasia, arteriovenous shunting, and intracranial hemorrhage. However, traditional surgical hemodynamic models and current GEAMs have limitations, particularly in replicating the spontaneous onset and progression of bAVMs or capturing the role of the perivascular microenvironment in disease development. This review evaluates the strengths and limitations of existing bAVM models, emphasizing their contributions to understanding the hemodynamic, molecular, and cellular mechanisms underlying bAVM pathogenesis. Emerging trends, such as advanced imaging, transcriptomic analyses, and patient-derived induced pluripotent stem cells, offer new avenues for studying bAVM development and progression. By integrating diverse modeling strategies and advancing translational efforts, innovative diagnostic and therapeutic approaches can be developed. This review aims to guide researchers in selecting appropriate models and fostering a deeper understanding of bAVMs, ultimately improving patient care.

Indexed as

Disease Models, AnimalIntracranial Arteriovenous MalformationsAnimalsHumansTelangiectasia, Hereditary HemorrhagicBrain arteriovenous malformations (bAVMs)Endothelial cells (ECs)Genetically engineered animal models (GEAMs)Hereditary hemorrhagic telangiectasia (HHT)MAPK signaling pathway

Identifiers

PMID42106885
PMCPMC13330304

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.